Significant improvement of hyperglycemia after treatment in a patient with primary aldosteronism

References (1)

1. Hsueh WA, Nicholas SB, Hamaty M, Baxter J, Sowers J. Endocrinology of hypertension. Felig P, Frohman LA. Endocrinology and Metabolism; (4th ed). Disorders of adrenal. McGraw -Hill, 2001, pp:588-590. 2-Ganguly A. Primary aldosteronism. N Eng J Med 1998; 339:1828-1833. 3-Giacchetti G, Sechi LA, Rilli S, Carey RM. The r e- nin-angiotensin-aldosterone system, glucose meta- bolism and diabetes. Trends Endocrinol Metab 2005; 3:120–126. 4-White PC. Disorders of aldosterone biosynt hesis and action. N Eng J Med 1994; 331: 250. 5-Carter BL, Einhorn PT, Brands M, He J, Cutler JA, Whelton PK, Bakris GL, Brancati FL, Cus hman WC, Oparil S, Wright JT Jr. Thiazide -induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. Hyperte nsion 2008; 52:30 –36. 6-Henquin JC. Triggering and amplifying pathways of regulation of insülin secretion by glucose. Diabetes 2000; 49:1751 –1760. 7-Plavinik FL, Rodrigues CI, Zanella MT, Ribeiro AB. Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 1992; 19(Suppl 2):26–29. 8-Corry DB, TuckM. The effect of aldost erone on glucose metabolism. Curr Hypertens Rep 2003; 5:106–109. 9-Reincke M, Meisinger C, Holle R, Quinkler M, Hahner S, Beuschlein F, Bidlingmaier M, Seissler J, Endres S. Participants of the German Conn's R egistry. Is primary aldosteronism ass ociated with diabetes mellitus? Results of the German Conn's Registry. Horm Metab Res 2010; 42: 435 -439 10-Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, Novello M, Favret G, Melis A, Cav a rape A, and Sechi LA. Insulin Sensitivity in Patients with Primary Aldosteronism: A Follow- Up Study. The Journal of Clinical Endocrinology & Metabolism 2006; 91(9) 3457–3463.